| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |